Back to UBS Group AG UBS Group AG

MISTMIST
Showing 7 of 25 quarters

Position history for UBS Group AGUBS Group AG's holdings in MILESTONE PHARMACEUTICALS IN

UBS Group AG holds 465,403 shares of MIST (MILESTONE PHARMACEUTICALS IN), worth $623,641 as of 2026-Q2. The position was decreased (-6.0% shares). MIST represents 0.0% of UBS Group AG's portfolio.

Current Value

$623,641

Current Shares

465,403

Total Value Change

+$412,407

Total Shares Change

+375,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
465,403
-6.0%
$623,6410.0%$1.34
0
2026-Q1
Increased
494,908
+0.6%
$588,9400.0%$1.65
24
2025-Q4
Increased
491,868
+23.7%
$993,5740.0%$1.96
30
2025-Q3
Increased
397,534
+23.2%
$795,0680.0%$2.03
30
2025-Q2
Increased
322,648
+189.3%
$625,9370.0%$1.86
39
2025-Q1
Increased
111,523
+24.6%
$89,2180.0%$0.88
18
2024-Q4
New
89,506
-
$211,2340.0%$2.25
35

Other major holders of MIST: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used